Hang Chen

About

Dr. Hang Chen is a pioneering thoracic surgeon whose research centers on minimally invasive surgical techniques for lung cancer, with a particular focus on elderly and high-risk patient populations. His landmark 2018 review on Mirizzi Syndrome (111 citations) established him as an authority on rare biliary complications, demonstrating his versatility across surgical specialties. Dr. Chen’s most impactful work, however, lies in comparing robotic-assisted thoracoscopic surgery (RATS) with video-assisted thoracoscopic surgery (VATS). His 2023 propensity-matched study on octogenarians with stage IA non-small cell lung cancer (17 citations) provided critical real-world evidence that robotic sub-lobar resection is both feasible and oncologically effective in the oldest patients. More recently, his 2024 analysis of lymph node dissection quality in stage N1-2 NSCLC (6 citations) drew on eleven years of high-volume center data to show that robotic lobectomy achieves superior nodal clearance and reduced early recurrence compared to VATS. Dr. Chen’s work is instrumental in shaping modern thoracic oncology, proving that advanced robotics can expand surgical options for fragile patients while maintaining rigorous oncologic standards.

Research Focus

Key Achievements

Top Papers

1. 1
   Current trends in the management of Mirizzi Syndrome

   111 citations · 2018
2. 2
   Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study

   17 citations · 2023
3. 3
   Quality of lymph node dissection and early recurrence in robotic versus thoracoscopic lobectomy for stage N1-2 non-small cell lung cancer: Eleven-year real-world data from a high-volume center

   6 citations · 2024

Key Collaborators

Contact & Links